Printer Friendly

Coromega's strategic initiatives.

The Coromega Company, Carlsbad, CA, a subsidiary of PlusPharma, has commenced several strategic initiatives. The makers of the Coromega[TM] brand omega 3 dietary supplement are in the process of completing a new production facility and planned expansion of the company's product line into new market segments. The company is also sponsoring clinical research at major U.S. universities and the Mayo Clinic. In addition, Brian Dyson, who spent over 35 years with The Coca-Cola Company, has been elected chairman of the board of PlusPharma.
COPYRIGHT 2004 Rodman Publications, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Coromega Company
Publication:Nutraceuticals World
Article Type:Brief Article
Geographic Code:1USA
Date:Sep 1, 2004
Previous Article:Product Safety Labs expands services to nutraceutical and dietary supplement industries.
Next Article:Rochem enters European market; signs exclusivity agreement.

Related Articles
Has your company outgrown its board? Here's how to tell.
Happenings at July Board of Directors' meeting.
Beyond advertising.
New age delivery: in response to consumer demand, product formulators have created a new generation of nutraceutical delivery systems that are...
GFOA and the evolution of performance measurement in government: through the years, performance measurement has defied the fate of both generals and...
DHA omega 3 supplements for children.

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters